The US Supreme Court declined to hear a case over the extent to which the federal drug enforcement agency can require a state official to hand over confidential prescription information.
The high court Monday denied a petition from New Hampshire’s prescription drug monitoring program over an investigative subpoena issued by the US Drug Enforcement Administration. The DEA sought data on Schedule II-IV controlled drug therapies prescribed to a specific individual.
The case would have given the justices an opportunity to weigh in on how DEA law enforcement efforts interact with state criminal laws.
The program alleged the subpoena violated state ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.